Top Markets
#1 Pleasing Gold Pleasing Gold +1,541.86%
#2 PulseChain PulseChain +57.52%
#3 Merlin's Seal BTC Merlin's Seal BTC +32.57%
#4 BOOK OF MEME BOOK OF MEME +32.28%
#5 Ontology Gas Ontology Gas +30.44%
#6 Unit Pump Unit Pump +23.94%
#7 Pump.fun Pump.fun +23.94%
#8 Nockchain Nockchain +21.37%
#9 Neiro Neiro +20.22%
#10 RSK Infrastructure Framework RSK Infrastructure Framework +19.14%
Coin of the day
Pleasing Gold Pleasing Gold
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
Classificação em ações #26781
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
Preço da ação
$0.52468396
Valor de mercado
$37.85M
Variação (1 dia)
1.23%
Variação (1 ano)
-4.53%
País
TW
Negociar Enimmune corporation (6564)

Categoria

Healthcare
Lucros da Enimmune corporation (6564)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Enimmune corporation, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Enimmune corporation de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH